Posts

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels. Medscape Medical News source https://www.medscape.com/viewarticle/encaleret-shows-rapid-response-autosomal-dominant-2026a1000jyu?src=rss

Urticaria Is Often a Team Sport for Derms and Allergists

Chronic urticaria is occasionally challenging, but dermatologists and allergists can help each other as well as the patient by combining their unique skills in difficult cases. Medscape Medical News source https://www.medscape.com/viewarticle/challenging-urticaria-often-team-sport-dermatologists-and-2026a1000jyq?src=rss

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study. Medscape Medical News source https://www.medscape.com/viewarticle/testosterone-prescribing-often-ignores-guidelines-2026a1000jym?src=rss

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements. Medscape Medical News source https://www.medscape.com/viewarticle/phase-3-palopegteriparatide-results-show-sustained-benefits-2026a1000jyi?src=rss

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored. Medscape Medical News source https://www.medscape.com/viewarticle/one-four-teen-girls-and-young-women-risk-pmos-2026a1000jxz?src=rss

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D. Medscape Medical News source https://www.medscape.com/viewarticle/teplizumab-approved-pediatric-stage-3-type-1-diabetes-2026a1000jxu?src=rss